GRANULES1 hour ago
Granules India Limited (granules) Gains Potential First-to-file Status on Ruxolitinib Extended-release Tablets ANDA
Granules India Limited (GRANULES) announced potential first-to-file status for its Ruxolitinib Extended-Release Tablets ANDA, aiming for 180 days of generic.